Intestinal microbiome and osteoarthritis

O.Yu. Gubska, А.А. Kuzminetes, V.M. Hutsul, I.O. Lavrenchuk


The study of intestinal microbiome is a very relevant topic popular among researchers, and a large number of studies are conducted. Currently, the amount of data on the human intestinal microbiome is growing at a high rate, both in health and in various pathological conditions. With an increase in the amount of the accumulated data, there is an expanded understanding that the microbiome is a very complex system, parts of which are in close relationship with the host organism, and react to environmental factors, including diet and medication intake. Researchers find more and more data on the correlation between medications, intestinal microflora and extraintestinal diseases. This article provides an overview of the data available in modern literature on the peculiarities of the state of intestinal microflora in patients with osteoarthritis, its possible impact on the disease pathogenesis, as well as changes that occur in the microbiome during treatment of osteoarthritis, particularly when using nonsteroidal anti-inflammatory drugs.


intestinal microbiome; osteoarthritis; nonsteroidal anti-inflammatory drugs; inflammation of the intestinal mucosa


Maruvada P, Leone V, Kaplan LM, Chang EB. The Human Microbiome and Obesity: Moving beyond Associations. Cell Host Microbe. 2017 Nov 8;22(5):589-599. doi: 10.1016/j.chom.2017.10.005.

Fändriks L. Roles of the gut in the metabolic syndrome: an overview. J Intern Med. 2017;281(4):319-336. doi:10.1111/joim.12584

Sanchez-Santos M, Judge A, Gulati M, et al. Association of metabolic syndrome with knee and hand osteoarthritis: A community-based study of women. Semin Arthritis Rheum. 2019 Apr;48(5):791-798. doi: 10.1016/j.semarthrit.2018.07.007.

Courties A, Sellam J, Berenbaum F. Metabolic syndrome-associated osteoarthritis. Curr Opin Rheumatol. 2017 Mar;29(2):214-222. doi: 10.1097/BOR.0000000000000373.

Gul'neva MIu, Noskov SM, Malafeeva EV. Intestinal microbiocenosis in the obese patients with osteoarthritis. Problemi Endocrinologii. 2012;58(3):12-15. (in Russian).

Picchianti-Diamanti A, Rosado MM, D’Amelio R. Infectious Agents and Inflammation: The Role of Microbiota in Autoimmune Arthritis. Front Microbiol. 2018 Jan 16;8:2696. doi: 10.3389/fmicb.2017.02696.

Zhong D, Wu C, Zeng X, Wang Q. The role of gut microbiota in the pathogenesis of rheumatic diseases. Clin Rheumatol. 2018 Jan;37(1):25-34. doi: 10.1007/s10067-017-3821-4.

Maeda Y, Takeda K. Role of Gut Microbiota in Rheumatoid Arthritis. J Clin Med. 2017 Jun 9;6(6). pii: E60. doi: 10.3390/jcm6060060.

Hernandez CJ. The Microbiome and Bone and Joint Disease. Curr Rheumatol Rep. 2017 Nov 4;19(12):77. doi: 10.1007/s11926-017-0705-1.

Huang ZY, Stabler T, Pei FX, Kraus VB. Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation. Osteoarthritis Cartilage. 2016 Oct;24(10):1769-1775. doi: 10.1016/j.joca.2016.05.008.

Schott EM, Farnsworth CW, Grier A, et al. Targeting the gut microbiome to treat the osteoarthritis of obesity. JCI Insight. 2018 Apr 19;3(8). pii: 95997. doi: 10.1172/jci.insight.95997.

Ibáñez L, Rouleau M, Wakkach A, Blin-Wakkach C. Gut microbiome and bone. Joint Bone Spine. 2019 Jan;86(1):43-47. doi: 10.1016/j.jbspin.2018.02.008.

Bultink IEM, Lems WF. Osteoarthritis and Osteoporosis: What Is the Overlap? Curr Rheumatol Rep. 2013 May;15(5):328. doi: 10.1007/s11926-013-0328-0.

Lorenz W, Buhrmann C, Mobasheri A, Lueders C, Shakibaei M. Bacterial lipopolysaccharides form procollagen-endotoxin complexes that trigger cartilage inflammation and degeneration: implications for the development of rheumatoid arthritis. Arthritis Res Ther. 2013;15(5):R111. doi: 10.1186/ar4291.

Wang Q, Huang S-Q, Li C-Q, Xu Q, Zeng Q-P. Akkermansia muciniphila May Determine Chondroitin Sulfate Ameliorating or Aggravating Osteoarthritis. Front Microbiol. 2017 Oct 9;8:1955. doi: 10.3389/fmicb.2017.01955.

Shang Q, Yin Y, Zhu L, Li G, Yu G, Wang X. Degradation of chondroitin sulfate by the gut microbiota of Chinese individuals. Int J Biol Macromol. 2016 May;86:112-8. doi: 10.1016/j.ijbiomac.2016.01.055.

Ahmedov VA, Ostapenko VA, Vinzhegina VA, Sudakova AN, Razheva NG. Effect of selective and non-selective non-steroidal anti-inflammatory drugs on the intestines and the hepatobiliary system. Eksperimental'naia i klinicheskaia gastroenterologiia. 2008;(3):72-75. (in Russian).

Gubska OYu, Kuzminets АА. NSAID-enterotoxicity: focus on the problem. Modern Gastroenterology. 2018;103(5):50-59. (in Ukrainian).

Gubska OYu, Taran AI, Lavrenchuk IO, Alyanova TS. Acetylsalicylic acid in the cardiological practice: the focus on enterotoxicity. Ukrainian Therapeutical Journal. 2018;(3-4):79-85. doi: 10.30978/UTJ2018-3-4-79. (in Ukrainian).

Bjarnason I, Scarpignato C, Holmgren E, Olszewski M, Rainsford KD, Lanas A. Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs. Gastroenterology. 2018 Feb;154(3):500-514. doi: 10.1053/j.gastro.2017.10.049.

Yoshikawa K, Kurihara C, Furuhashi H, et al. Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling. J Gastroenterol. 2017 Jan;52(1):61-71. doi: 10.1007/s00535-016-1205-1.

Edogawa S, Peters SA, Jenkins GD, et al. Sex differences in NSAID-induced perturbation of human intestinal barrier function and microbiota. FASEB J. 2018 Jun 13:fj201800560R. doi: 10.1096/fj.201800560R.

Li Y, Luo W, Deng Z, Lei G. Diet-Intestinal Microbiota Axis in Osteoarthritis: A Possible Role. Mediators Inflamm. 2016;2016:3495173. doi: 10.1155/2016/3495173.

Haro C, Rangel-Zúñiga OA, Alcalá-Díaz JF, et al. Intestinal Microbiota Is Influenced by Gender and Body Mass Index. PLoS One. 2016 May 26;11(5):e0154090. doi: 10.1371/journal.pone.0154090.

Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017 Aug;151(4):363-374. doi: 10.1111/imm.12760.

Sakkas LI, Bogdanos DP. Multiple hit infection and autoimmunity: the dysbiotic microbiota–ACPA connection in rheumatoid arthritis. Curr Opin Rheumatol. 2018 Jul;30(4):403-409. doi: 10.1097/BOR.0000000000000503.

Muraki M, Fujiwara Y, Machida H, et al. Role of small intestinal bacterial overgrowth in severe small intestinal damage in chronic non-steroidal anti-inflammatory drug users. Scand J Gastroenterol. 2014 Mar;49(3):267-273. doi: 10.3109/00365521.2014.880182.

Scarpignato C, Dolak W, Lanas A, et al. Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans. Gastroenterology. 2017 Apr;152(5):980-982.e3. doi: 10.1053/j.gastro.2016.12.007.

Montalto M, Gallo A, Curigliano V, et al. Clinical trial: The effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy - A randomized, double-blind, cross-over, placebo-controlled study. Aliment Pharmacol Ther. 2010 Jul;32(2):209-14. doi: 10.1111/j.1365-2036.2010.04324.x.

Endo H, Higurashi T, Hosono K, et al. Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. J Gastroenterol. 2011 Jul;46(7):894-905. doi: 10.1007/s00535-011-0410-1.

Suzuki T, Masui A, Nakamura J, et al. Yogurt Containing Lactobacillus gasseri Mitigates Aspirin-Induced Small Bowel Injuries: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. Digestion. 2017;95(1):49-54. doi: 10.1159/000452361.

Otani K, Tanigawa T, Watanabe T, et al. Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage. Digestion. 2017;95(1):22-28. doi: 10.1159/000452356.

Vakhrushev IaM, Zagrebina EA. Clinical and functional changes of the small intestine in the treatment of osteoarthritis with nonsteroid anti-inflammatory drugs. Eksperimental'naia i klinicheskaia gastroenterologiia. 2010;(3):18-22. (in Russian).

Rogers MAM, Aronoff DM. The influence of non-steroidal anti-inflammatory drugs on the gut microbiome. Clin Microbiol Infect. 2016 Feb;22(2):178.e1-178.e9. doi: 10.1016/j.cmi.2015.10.003.

Bokulich NA, Battaglia T, Aleman JO, Walker JM, Blaser MJ, Holt PR. Celecoxib does not alter intestinal microbiome in a longitudinal diet-controlled study. Clin Microbiol Infect. 2016 May;22(5):464-5. doi: 10.1016/j.cmi.2016.01.013.

Coulson S, Butt H, Vecchio P, Gramotnev H, Vitetta L. Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles. Inflammopharmacology. 2013 Feb;21(1):79-90. doi: 10.1007/s10787-012-0146-4.

Lei M, Guo C, Wang D, Zhang C, Hua L. The effect of probiotic Lactobacillus casei Shirota on knee osteoarthritis: a randomised double-blind, placebo-controlled clinical trial. Benef Microbes. 2017 Oct 13;8(5):697-703. doi: 10.3920/BM2016.0207.

Copyright (c) 2019 GASTROENTEROLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2020


   Seo анализ сайта